William W. Witt
University of Kentucky
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by William W. Witt.
Weed Science | 2012
Jason K. Norsworthy; Sarah M. Ward; David R. Shaw; Rick Llewellyn; Robert L. Nichols; Theodore M. Webster; Kevin W. Bradley; George B. Frisvold; Stephen B. Powles; Nilda R. Burgos; William W. Witt; Michael Barrett
Herbicides are the foundation of weed control in commercial crop-production systems. However, herbicide-resistant (HR) weed populations are evolving rapidly as a natural response to selection pressure imposed by modern agricultural management activities. Mitigating the evolution of herbicide resistance depends on reducing selection through diversification of weed control techniques, minimizing the spread of resistance genes and genotypes via pollen or propagule dispersal, and eliminating additions of weed seed to the soil seedbank. Effective deployment of such a multifaceted approach will require shifting from the current concept of basing weed management on single-year economic thresholds.
Neuromodulation | 2007
Timothy R. Deer; Elliot S. Krames; Samuel J. Hassenbusch; Allen W. Burton; David Caraway; Stuart DuPen; James C. Eisenach; Michael A. Erdek; Eric Grigsby; Phillip Kim; Robert M. Levy; Gladstone McDowell; Nagy Mekhail; Sunil Panchal; Joshua Prager; Richard Rauck; Michael Saulino; Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; K. Dean Willis; William W. Witt; Kenneth A. Follett; Marc A. Huntoon; Leong Liem; James P. Rathmell; Mark S. Wallace; Eric Buchser; Michael Cousins
Background. Expert panels of physicians and nonphysicians in the field of intrathecal therapies convened in 2000 and 2003 to make recommendations for the rational use of intrathecal analgesics based on the preclinical and clinical literature known up to those times. An expert panel of physicians convened in 2007 to update previous recommendations and to form guidelines for the rational use of intrathecal opioid and nonopioid agents.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark T. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh
Introduction: The use of intrathecal (IT) infusion of analgesic medications to treat patients with chronic refractory pain has increased since its inception in the 1980s, and the need for clinical research in IT therapy is ongoing. The Polyanalgesic Consensus Conference (PACC) panel of experts convened in 2000, 2003, and 2007 to make recommendations on the rational use of IT analgesics based on preclinical and clinical literature and clinical experiences.
Neuromodulation | 2012
Timothy R. Deer; Robert M. Levy; Joshua Prager; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail
Introduction: Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options fail. This therapy is well established in the literature, has shown efficacy, and is an important tool for the treatment of both cancer and noncancer pain; however, it has become clear in recent years that intrathecal drug delivery is associated with risks for serious morbidity and mortality.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; Allen W. Burton; Eric Buchser; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Phillip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; B. Todd Sitzman; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail
Introduction: Trialing for intrathecal pump placement is an essential part of the decision‐making process in placing a permanent device. In both the United States and the international community, the proper method for trialing is ill defined.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh
Introduction: Continuous intrathecal infusion of drugs to treat chronic pain and spasticity has become a standard part of the algorithm of care. The use of opioids has been associated with noninfectious inflammatory masses at the tip of the intrathecal catheter, which can result in neurologic complications.
Weed Technology | 2002
Jason A. Ferrell; William W. Witt
Abstract: Glyphosate was compared with other commonly used corn herbicides at three locations in Kentucky in 1998 and 1999. Sequential glyphosate treatments provided greater than 87% control of common cocklebur, ivyleaf morningglory, common lambsquarters, and giant ragweed. Control of these species with glyphosate treatments was similar to the control with atrazine plus other postemergence (POST) herbicides. Generally, treatments containing s-triazines and chloracetamides applied to the soil surface were not as effective as sequential glyphosate or atrazine plus POST herbicides. Corn yield was not significantly different at any location or for any year, whereas differences in net return occurred at one location in 1998. Nomenclature: Atrazine; chloracetamides; glyphosate; s-triazines; common cocklebur, Xanthium strumarium L. #3 XANST; common lambsquarters, Chenopodium album L. # CHEAL; giant ragweed, Ambrosia trifida L. # AMBTR; ivyleaf morningglory, Ipomoea hederacea L. Jacq. # IPOHE; corn, Zea mays L. ‘DeKalb 626RR’. Additional index words: Acetochlor, dicamba, Digitaria sanguinalis L. Scop. DIGSA, dimethenamid, giant foxtail, large crabgrass, 1-(4-methoxy-6-methyl-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)-phenylsulfonyl]-urea, metolachlor, net return, primisulfuron, prosulfuron, Roundup Ready® corn, Setaria faberi Herrm. SETFA, simazine. Abbreviations: ASN, as needed; MP, mid-postemergence; POST, postemergence; PRE, preemergence; REG, regrowth.
Neuromodulation | 2008
Timothy R. Deer; Elliot S. Krames; Samuel J. Hassenbusch; Allen W. Burton; David Caraway; Stuart DuPen; James C. Eisenach; Michael A. Erdek; Eric Grigsby; Phillip Kim; Robert M. Levy; Gladstone McDowell; Nagy Mekhail; Sunil Panchal; Joshua Prager; Richard Rauck; Michael Saulino; Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; K. Dean Willis; William W. Witt; Kenneth A. Follett; Mark Huntoon; Leong Liem; James P. Rathmell; Mark S. Wallace; Eric Buchser; Michael Cousins
Background. Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma.
Weed Science | 2000
Jerome B. Weber; Gail G. Wilkerson; H. Michael Linker; John W. Wilcut; Ross B. Leidy; Scott A. Senseman; William W. Witt; Michael Barrett; William K. Vencill; David R. Shaw; Thomas C. Mueller; Donnie K. Miller; Barry J. Brecke; Ronald E. Talbert; Thomas F. Peeper
Abstract Herbicide soil/solution distribution coefficients (Kd) are used in mathematical models to predict the movement of herbicides in soil and groundwater. Herbicides bind to various soil constituents to differing degrees. The universal soil colloid that binds most herbicides is organic matter (OM), however clay minerals (CM) and metallic hydrous oxides are more retentive for cationic, phosphoric, and arsenic acid compounds. Weakly basic herbicides bind to both organic and inorganic soil colloids. The soil organic carbon (OC) affinity coefficient (Koc) has become a common parameter for comparing herbicide binding in soil; however, because OM and OC determinations vary greatly between methods and laboratories, Koc values may vary greatly. This proposal discusses this issue and offers suggestions for obtaining the most accurate Kd, Freundlich constant (Kf), and Koc values for herbicides listed in the WSSA Herbicide Handbook and Supplement. Nomenclature: Readers are referred to the WSSA Herbicide Handbook and Supplement for the chemical names of the herbicides.
Neuromodulation | 2008
Timothy R. Deer; Elliot S. Krames; Samuel J. Hassenbusch; Allen W. Burton; David Caraway; Stuart DuPen; James C. Eisenach; Michael A. Erdek; Eric Grigsby; Phillip Kim; Robert M. Levy; Gladstone McDowell; Nagy Mekhail; Sunil Panchal; Joshua Prager; Richard Rauck; Michael Saulino; Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; K. Dean Willis; William W. Witt; Kenneth A. Follett; Mark Huntoon; Leong Liem; James P. Rathmell; Mark S. Wallace; Eric Buchser; Michael Cousins
Background. Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics, based on the preclinical and clinical literature known up to those times, presentations of the expert panels, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and nonphysicians has convened in 2007 to update information known regarding IT therapies and to update information on new and novel opioid and nonopioid analgesic compounds that might show promise for IT use.